1.
Toll-like receptor signaling and stages of addiction
by Crews, Fulton T
Psychopharmacology, 2017-02-17, Vol.234 (9-10), p.1483-1498
2.
A potential role for the gut microbiome in substance use disorders
by Meckel, Katherine R
Psychopharmacology, 2019-04-14, Vol.236 (5), p.1513-1530
3.
Adjuvants for vaccines to drugs of abuse and addiction
by Alving, Carl R
Vaccine, 2014, Vol.32 (42), p.5382-5389
4.
Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats
by McClenahan, Samantha J
Vaccine, 2020-01-10, Vol.38 (2), p.336-344
5.
Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists
by Yang, Fang
Psychopharmacology, 2019-02-06, Vol.236 (10), p.2899-2907
6.
Is immunotherapy an opportunity for effective treatment of drug addiction?
by Zalewska-Kaszubska, Jadwiga
Vaccine, 2015, Vol.33 (48), p.6545-6551
7.
Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines
by Duryee, Michael J
Vaccine, 2009, Vol.27 (22), p.2981-2988
8.
The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS
by Hawk, Mary
AIDS care, 2012-05-01, Vol.24 (5), p.577-582
9.
Immune response to hepatitis B vaccination in drug using populations: A systematic review and meta-regression analysis
by Kamath, Geetanjali R
Vaccine, 2014, Vol.32 (20), p.2265-2274
10.
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
by Keen, Larry
Journal of behavioral medicine, 2015-03-03, Vol.38 (3), p.527-534
11.
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers
by NERI, S
Psychopharmacologia, 2005, Vol.179 (3), p.700-704
12.
Current challenges for the creation of effective vaccines against drugs of abuse
by Moreno, Amira Y
Expert review of vaccines, 2011-12-01, Vol.10 (12), p.1637-1639
13.
USA homes in on prescription drug abuse
by Devi, Sharmila
The Lancet (British edition), 2011, Vol.378 (9790), p.473-474
14.
Therapeutic vaccines and immunotherapies: current challenges and new frontiers
by Oviedo-Orta, Ernesto
Expert review of vaccines, 2013-03-01, Vol.12 (3), p.243-244
15.
Suppression of psychoactive effects of cocaine by active immunization
by Carrera, M. Rocío A
Nature (London), 1995-12-14, Vol.378 (6558), p.727-730
16.
Therapeutic vaccines for substance dependence
by Haney, Margaret
Expert review of vaccines, 2004-02-01, Vol.3 (1), p.11-18
17.
Therapeutic Applications of Monoclonal Antibodies
by Berger, Mitchell
The American journal of the medical sciences, 2002-07, Vol.324 (1), p.14-30
19.
Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection
by van Asten, Liselotte
AIDS (London), 2004, Vol.18 (14), p.1885-1893
20.
Modulation of the Proteome of Peripheral Blood Mononuclear Cells from HIV-1-Infected Patients by Drugs of Abuse
by Reynolds, Jessica L
Journal of clinical immunology, 2009-06-20, Vol.29 (5), p.646-656
